CBP Finds Countries of Origin for Several Pharmaceuticals Are Source of Active Ingredients

The countries of origin for several pharmaceuticals processed into dosage form in India are several countries in the European Union and Taiwan, where the active ingredients were made, CBP said in a final determination. The processing in India does not result in a change in name or use, nor does a change in character result because each maintains the same chemical and physical properties both before and after the Indian processing, CBP said. As a result, the agency found that “the country of origin of the meloxicam tablets is Italy for purposes of U.S. Government procurement, that the country of origin of the bimatoprost ophthalmic solution is Taiwan for purposes of U.S. Government procurement, that the country of origin of the niacin ER tablets is Belgium or Switzerland for purposes of U.S. Government procurement, that the country of origin of the calcium acetate capsules is the Netherlands for purposes of U.S. Government procurement, that the country of origin of the quinine sulfate capsules is Germany for purposes of U.S. Government procurement, and that the country of origin of the pravastatin sodium tablets is Taiwan for purposes of U.S. Government procurement,” it said.